Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IMUX

Immunic Inc

May 06 • 09:59AM ET

10.73

-0.55 -4.83 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: FATE IOVA AGEN KPTI ADAP MCRB AFMD IMTX ALDX ZLAB

| Held by: VTI VXF SURI IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-7.46	Insider Own	1.34%	Shs Outstand	13.62M	Perf Week	7.03%
Market Cap	137.67M	Forward P/E	-	EPS next Y	-3.13	Insider Trans	0.00%	Shs Float	13.44M	Perf Month	-9.79%
Enterprise Value	122.77M	PEG	-	EPS next Q	-0.69	Inst Own	63.17%	Short Float	6.20%	Perf Quarter	73.12%
Income	-97.17M	P/S	-	EPS this Y	47.20%	Inst Trans	-	Short Ratio	2.00	Perf Half Y	43.50%
Sales	0.00M	P/B	-	EPS next Y	4.43%	ROA	-299.36%	Short Interest	0.83M	Perf YTD	101.14%
Book/sh	-0.55	P/C	8.89	EPS next 5Y	19.02%	ROE	-1653.15%	52W High	15.10 -28.91%	Perf Year	0.33%
Cash/sh	1.21	P/FCF	-	EPS past 3/5Y	45.16% 25.99%	ROIC	-	52W Low	5.06 112.07%	Perf 3Y	-35.33%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	9.65% 10.47%	Perf 5Y	-90.96%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	27.88%	Oper. Margin	-	ATR (14)	1.04	Perf 10Y	-99.68%
Dividend Ex-Date	-	Quick Ratio	0.75	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	51.62	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.75	EPS Q/Q	42.59%	SMA20	3.27%	Beta	1.20	Target Price	49.88
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-3.63%	Rel Volume	2.42	Prev Close	11.28
Employees	92	LT Debt/Eq	-	Earnings	Feb 26 BMO	SMA200	24.09%	Avg Volume	417.30K	Price	10.73
IPO	Apr 17, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-5.56% -	Trades		Volume	121,821	Change	-4.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)